Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-19

Clinical Trial Update: Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing GP2017 with Humira in rheumatoid arthritis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GP2017 (adalimumab)
  • Humira (adalimumab)

Snippet

Sponsor: Sandoz | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-19